Unitedhealth Group Incorporated UNH

Revenue Intelligence Report • 70 quarters of SEC filing data • Updated 2026-03-06

UnitedHealth Group Incorporated has demonstrated strong revenue growth, with the latest quarterly revenue reaching $113.2 billion, driven primarily by efficient SG&A spending that generates $13.15 in long-run revenue for every dollar invested. The company's model shows a high degree of accuracy, with a mere 1.2% error in recent predictions, reflecting its robust financial forecasting capabilities. For the upcoming fiscal year, UnitedHealth is projected to achieve $476 billion in revenue, representing a 6.4% year-over-year increase, indicating a positive outlook for continued growth and profitability. Investors can expect solid returns as the company effectively leverages its operational efficiencies to drive revenue expansion.

Next FY Revenue
$475.99B
+6.4% YoY
SG&A Multiplier
$13.15 per $1
Model Accuracy
1.8% MAPE
Holdout validation: The model predicted $112B vs the actual $113B — an error of 1.2%.
Note: Unitedhealth Group Incorporated does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

UNH Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $112B $113B $109B – $115B +11.0% ✓ In range
Q2 2026 $115B $111B – $120B +5.3%
Q3 2026 $117B $112B – $122B +5.1%
Q4 2026 $121B $115B – $127B +7.2%
Q1 2027 $122B $115B – $129B +7.8%

How Spending Drives Revenue

UNH Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch